| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.31T | 7.79T | 7.25T | 9.19T | 8.51T | 6.33T |
| Gross Profit | 1.15T | 1.15T | 1.07T | 1.05T | 895.33B | 675.42B |
| EBITDA | 554.44B | 908.90B | 741.87B | 478.72B | 383.68B | 249.61B |
| Net Income | 515.00B | 502.96B | 471.41B | 543.00B | 424.32B | 223.26B |
Balance Sheet | ||||||
| Total Assets | 10.02T | 9.20T | 8.92T | 7.95T | 8.26T | 6.94T |
| Cash, Cash Equivalents and Short-Term Investments | 518.10B | 830.89B | 506.27B | 610.31B | 578.72B | 745.98B |
| Total Debt | 2.70T | 2.54T | 2.41T | 2.35T | 2.68T | 2.69T |
| Total Liabilities | 5.73T | 5.43T | 5.36T | 5.12T | 6.06T | 5.27T |
| Stockholders Equity | 4.14T | 3.63T | 3.46T | 2.88T | 2.24T | 1.81T |
Cash Flow | ||||||
| Free Cash Flow | 396.55B | 420.39B | 289.10B | 502.07B | 210.11B | 272.98B |
| Operating Cash Flow | 539.74B | 597.95B | 442.47B | 606.33B | 311.92B | 397.07B |
| Investing Cash Flow | -71.60B | -395.30B | -334.43B | 163.77B | -79.66B | -115.97B |
| Financing Cash Flow | -333.94B | -122.03B | -254.17B | -773.56B | -419.64B | -68.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $62.59B | 13.77 | 13.39% | 2.33% | 10.75% | 27.26% | |
71 Outperform | $8.32B | 23.29 | 20.28% | 0.63% | 1.23% | -22.77% | |
69 Neutral | $149.41B | 24.26 | 31.25% | 2.24% | 7.48% | 9.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $3.64B | 12.77 | 38.69% | 1.01% | -3.95% | -74.65% | |
55 Neutral | $79.17B | 37.06 | 71.89% | 1.82% | -13.09% | -20.63% | |
49 Neutral | $4.86B | -14.82 | -10.91% | 27.59% | -8.45% | 27.66% |